Profile data is unavailable for this security.
About the company
Creo Medical Group plc is a medical device company. The Company is focused on the development and commercialization of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. It is engaged in the research, development and distribution of electrosurgical medical devices relating to the field of surgical endoscopy. The Company has developed the CROMA powered by Kamaptive full-spectrum adaptive technology, which provides optimized surgical capability and patient outcomes. The Kamaptive is a seamless, intuitive integration of multi-modal energy sources. Its CROMA delivers bipolar radiofrequency (RF) energy for precise localized cutting and focused high frequency microwave (MW) energy for controlled coagulation and ablation via a single accessory port. This technology, combined with its range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions.
- Revenue in GBP (TTM)2.20m
- Net income in GBP12.60m
- Incorporated2016
- Employees133.00
- LocationCreo Medical Group PLCUnit 2 Beaufort Park,, Beaufort Park WayCHEPSTOW NP16 5UHUnited KingdomGBR
- Phone+44 12 9160 6005
- Websitehttps://creomedical.com/
Peer analysis
| Company | Revenue (TTM) | Net income (TTM) |
|---|---|---|
| Abingdon Health PLC | 8.43m | -3.42m |
| Inspiration Healthcare Group PLC | 45.20m | -11.44m |
| Aptamer Group PLC | 1.20m | -2.42m |
| Renalytix PLC | 2.20m | -14.99m |
| Aoti Inc | 46.93m | 1.73m |
| Ondine Biomedical Inc | 1.18m | -12.84m |
| Inspecs Group PLC | 192.83m | -3.31m |
| Creo Medical Group PLC | 2.20m | 12.60m |
| SDI Group PLC | 69.29m | 4.59m |
| EKF Diagnostics Holdings PLC | 50.22m | 6.12m |
| Tristel Plc | 46.46m | 6.64m |
Institutional shareholders
| Holder | Shares | % Held |
|---|---|---|
| M&G Investment Management Ltd.as of 30 Sep 2025 | 51.23m | 12.42% |
| Canaccord Genuity Wealth Ltd.as of 31 Dec 2024 | 36.17m | 8.77% |
| River Global Investors LLPas of 31 Mar 2025 | 20.83m | 5.05% |
| AXA Investment Managers UK Ltd.as of 31 Dec 2025 | 14.50m | 3.52% |
| Baillie Gifford & Co.as of 31 Dec 2025 | 10.00m | 2.42% |
| Amati Global Investors Ltd.as of 31 Oct 2025 | 6.62m | 1.60% |
| BlackRock Investment Management (UK) Ltd.as of 30 Sep 2025 | 6.55m | 1.59% |
| Chelverton Asset Management Ltd.as of 30 Jun 2025 | 6.17m | 1.50% |
| Octopus Investments Ltd.as of 31 Dec 2025 | 5.35m | 1.30% |
| Border to Coast Pensions Partnership Ltd.as of 31 Mar 2025 | 4.93m | 1.20% |
